Trial intelligence / Profile preview

STOPOXY: Discontinuing Oxytocin During the Active Phase of Labor

NCT03991091Phase 4Completed

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Jan 2020
Primary completion
Apr 2022
Modality
Peptides
Countries
1
01

Overview

A Phase 4 trial of oxytocin in neonatal morbidity, sponsored by Assistance publique - Hôpitaux de Paris. Started Jan 2020; status: completed.

02

Drugs

oxytocin
03

Conditions

neonatal morbidity

Beyond the preview

Go deeper on NCT03991091.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03991091.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call